(NEOG) Neogen - Ratings and Ratios

Neogen Corporation (NASDAQ:NEOG) is a global leader in food and animal safety, operating through two core segments: Food Safety and Animal Safety. The Food Safety segment specializes in diagnostic test kits and related products to detect contaminants in food and animal feed, including foodborne pathogens, natural toxins, allergens, and residues. It also offers advanced sanitation testing, genomics-based diagnostics, and software solutions for data analysis. These products serve a wide range of industries, including milling, meat processing, dairy, seafood, healthcare, and dietary supplements. The Animal Safety segment provides a diverse portfolio of products and services for veterinary care, livestock management, and animal health, including pharmaceuticals, vaccines, diagnostics, and pest control solutions. These offerings are distributed through veterinarians, retailers, and animal health distributors, catering to companion animals, livestock producers, and research institutions. Headquartered in Lansing, Michigan, Neogen has been a key player in safety solutions since its inception in 1981.

From a technical perspective, NEOG stock is currently trading at $5.75, below its 20-day SMA of $5.46 and significantly below its 50-day SMA of $7.79 and 200-day SMA of $12.69. This indicates a bearish trend with potential downside risks. The average trading volume over 20 days is 7,194,438 shares, with an ATR of 0.57, suggesting moderate volatility. On the fundamental side, Neogen has a market cap of $1.247B, with a forward P/E ratio of 16.00, indicating expectations for future earnings growth. However, the current P/E ratio is non-existent, likely due to negative earnings. The P/B ratio of 0.41 and P/S ratio of 1.23 suggest undervaluation relative to book value and sales, respectively. The RoE of -18.24% highlights profitability challenges.

Based on the technical and fundamental data, NEOG may face short-term headwinds due to its bearish price action and negative profitability metrics. However, its forward P/E and low P/S ratio suggest potential for recovery if the company can address its profitability issues and leverage its strong market position in food and animal safety.